home / stock / lxrx / lxrx short
Short Information | Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 10,758,858 |
Total Actual Volume | 52,539,719 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 537,943 |
Average Short Percentage | 22.09% |
Is there a LXRX Short Squeeze or Breakout about to happen?
See the LXRX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-03-2024 | $1.62 | $1.66 | $1.66 | $1.59 | 1,674,064 | 399,531 | 23.87% |
07-02-2024 | $1.69 | $1.6 | $1.7094 | $1.6 | 1,764,941 | 567,110 | 32.13% |
07-01-2024 | $1.68 | $1.675 | $1.765 | $1.66 | 1,616,733 | 358,359 | 22.17% |
06-28-2024 | $1.76 | $1.68 | $1.76 | $1.64 | 4,749,863 | 513,912 | 10.82% |
06-27-2024 | $1.69 | $1.74 | $1.76 | $1.64 | 1,831,441 | 399,152 | 21.79% |
06-26-2024 | $1.69 | $1.68 | $1.715 | $1.64 | 2,103,646 | 607,610 | 28.88% |
06-25-2024 | $1.82 | $1.7 | $1.83 | $1.69 | 1,646,941 | 375,133 | 22.78% |
06-24-2024 | $1.85 | $1.81 | $1.85 | $1.75 | 1,743,720 | 440,937 | 25.29% |
06-21-2024 | $1.78 | $1.85 | $1.895 | $1.73 | 6,896,627 | 492,070 | 7.13% |
06-20-2024 | $1.75 | $1.75 | $1.795 | $1.715 | 2,165,793 | 454,267 | 20.97% |
06-18-2024 | $1.72 | $1.75 | $1.8 | $1.69 | 2,516,711 | 813,407 | 32.32% |
06-17-2024 | $1.91 | $1.72 | $2.03 | $1.71 | 4,405,183 | 1,103,941 | 25.06% |
06-14-2024 | $1.83 | $1.82 | $1.875 | $1.78 | 1,598,433 | 265,272 | 16.6% |
06-13-2024 | $1.9 | $1.83 | $1.93 | $1.81 | 1,468,339 | 282,075 | 19.21% |
06-12-2024 | $1.94 | $1.91 | $2.005 | $1.9 | 2,571,772 | 479,235 | 18.63% |
06-11-2024 | $1.89 | $1.93 | $1.955 | $1.8325 | 2,224,469 | 420,488 | 18.9% |
06-10-2024 | $1.73 | $1.9 | $1.9 | $1.72 | 3,853,815 | 838,812 | 21.77% |
06-07-2024 | $1.71 | $1.75 | $1.75 | $1.7 | 1,045,405 | 227,328 | 21.75% |
06-06-2024 | $1.92 | $1.75 | $1.93 | $1.74 | 3,296,799 | 1,002,172 | 30.4% |
06-05-2024 | $1.79 | $1.94 | $1.94 | $1.72 | 3,365,024 | 718,047 | 21.34% |
News, Short Squeeze, Breakout and More Instantly...
Lexicon Pharmaceuticals Inc. Company Name:
LXRX Stock Symbol:
NASDAQ Market:
Lexicon Pharmaceuticals Inc. Website:
Lexicon Seeks Approval for Sotagliflozin as an Adjunct to Insulin Therapy for Glycemic Control in People with Type 1 Diabetes and Chronic Kidney Disease Company Anticipates Six Month Review and Potential Launch in Early 2025 THE WOODLANDS, Texas, June 21, 2024 (GLOBE NEWSWIR...
Clinical trial of LX9211, an investigational non-opioid investigational therapy, demonstrated clinically significant benefits for people with diabetic peripheral neuropathic pain (DPNP) Investigators conclude that clinical outcomes of RELIEF-DPN 1 support commencement of Lexiconȁ...
New analysis of the pivotal Phase 3 SOLOIST-WHF trial demonstrates INPEFA cost-effectiveness Findings consistent with another study recently published in the Journal of Comparative Effectiveness Research THE WOODLANDS, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- Lexicon Pha...